MBT CEM KEEL TIB TRAY SZ2
Report
- Report Number
- 1818910-2014-31522
- Event Type
- Injury
- Date Received
- November 11, 2014
- Date of Event
- October 17, 2014
- Report Date
- October 17, 2014
- Manufacturer
- DEPUY IRELAND 9616671
- Product Code
- NJL
- PMA / PMN Number
- PP830055
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NC, US
- Reporter Occupation
- PHYSICIAN
Narratives
ADDITIONAL NARRATIVE: THE DEVICES ASSOCIATED WITH THIS REPORT WERE NOT RETURNED. A COMPLAINT DATABASE SEARCH ON THE PROVIDED SMARTSET GHV GENTAMICIN 40G (PRODUCT CODE 545035500, LOT NUMBER 3329660) FOUND AN ADDITIONAL REPORT AND A DHR REVIEW WAS CONDUCTED ((B)(4)). REVIEW OF THE DEVICE HISTORY RECORDS DID NOT REVEAL ANY RELATED MANUFACTURING DEVIATIONS OR ANOMALIES. A COMPLAINT DATABASE SEARCH FINDS NO OTHER REPORTED INCIDENTS AGAINST THE REMAINING PRODUCT AND LOT COMBINATION. THE INITIAL REPORTING STATED NO ADDITIONAL INVESTIGATIONAL INPUTS WERE AVAILABLE. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITH THE INFORMATION PROVIDED. BASED ON THE INABILITY TO IDENTIFY ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.
THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.(B)(4).
PATIENT WAS REVISED TO ADDRESS TIBIAL LOOSENING AT THE CEMENT INTERFACE. DEPUY CEMENT WAS USED. INSTABILITY WAS ALSO REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 726990 | MBT CEM KEEL TIB TRAY SZ2 | KNEE TIBIAL TRAY | NJL | DEPUY IRELAND 9616671 | 3359291 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 64 YR | Required Intervention |